Publicação

Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese Gastroenterologists

Ver documento

Detalhes bibliográficos
Resumo:Abstract Background: In 2018, the authors surveyed the clinical practices among Portuguese gastroenterologists (PGEs) regarding treatment targets in Crohn’s disease (CD) and ulcerative colitis (UC). Since then, new evidence has emerged supporting additional targets, such as transmural remission and histological remission. This study provides an updated assessment of treatment practices among PGE with special emphasis on these new targets. Methods: Using the Portuguese Inflammatory bowel disease Study Group (GEDII) physician database, we invited PGE to participate in an anonymous online survey. Results: Fifty-six physicians agreed to participate in the study. Deep remission, steroid-free clinical remission, endoscopic remission, and biomarker remission were ranked among the most important treatment targets in CD (89%, 80%, 89%, and 84%, respectively) and UC (82%, 84%, 79%, and 84%, respectively). In CD, transmural remission was considered a target by 70% of participants, with 48% agreeing to intensify treatment to achieve it. In UC, histological remission was aimed by only 45% of PGE with most (88%) being unwilling to intensify treatment to achieve this goal. Physicians were more likely to seek endoscopic remission in CD and UC in younger and healthier patients, compared to older patients with comorbidities. Conclusion: PGEs are increasingly pursuing tougher treatment targets such as transmural remission in CD and, to a lesser extent, histological remission in UC. Physicians are more willing to escalate treatment to achieve endoscopic remissioninyounger patients.
Autores principais:Sousa,Diogo Couto
Outros Autores:Fernandes,Samuel Raimundo; Bernardo,Sónia; Correia,Luís; Cortez-Pinto,Helena; Magro,Fernando
Assunto:Inflammatory bowel disease Transmural remission Histological remission
Ano:2025
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Fundação para a Ciência e Tecnologia
Idioma:inglês
Origem:SciELO Portugal
_version_ 1868442041351929856
author Sousa,Diogo Couto
author2 Fernandes,Samuel Raimundo
Bernardo,Sónia
Correia,Luís
Cortez-Pinto,Helena
Magro,Fernando
author2_role author
author
author
author
author
author_facet Sousa,Diogo Couto
Fernandes,Samuel Raimundo
Bernardo,Sónia
Correia,Luís
Cortez-Pinto,Helena
Magro,Fernando
author_role author
country_str PT
creators_json_txt [{\"Person.name\":\"Sousa,Diogo Couto\"},{\"Person.name\":\"Fernandes,Samuel Raimundo\"},{\"Person.name\":\"Bernardo,Sónia\"},{\"Person.name\":\"Correia,Luís\"},{\"Person.name\":\"Cortez-Pinto,Helena\"},{\"Person.name\":\"Magro,Fernando\"}]
datacite.creators.creator.creatorName.fl_str_mv Sousa,Diogo Couto
Fernandes,Samuel Raimundo
Bernardo,Sónia
Correia,Luís
Cortez-Pinto,Helena
Magro,Fernando
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Inflammatory bowel disease
Transmural remission
Histological remission
datacite.titles.title.fl_str_mv Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese Gastroenterologists
dc.creator.none.fl_str_mv Sousa,Diogo Couto
Fernandes,Samuel Raimundo
Bernardo,Sónia
Correia,Luís
Cortez-Pinto,Helena
Magro,Fernando
dc.format.none.fl_str_mv text/html
dc.identifier.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452025000400047
dc.language.none.fl_str_mv eng
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Gastrenterologia
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.source.none.fl_str_mv GE-Portuguese Journal of Gastroenterology v.32 n.4 2025
dc.subject.none.fl_str_mv Inflammatory bowel disease
Transmural remission
Histological remission
dc.title.fl_str_mv Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese Gastroenterologists
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description Abstract Background: In 2018, the authors surveyed the clinical practices among Portuguese gastroenterologists (PGEs) regarding treatment targets in Crohn’s disease (CD) and ulcerative colitis (UC). Since then, new evidence has emerged supporting additional targets, such as transmural remission and histological remission. This study provides an updated assessment of treatment practices among PGE with special emphasis on these new targets. Methods: Using the Portuguese Inflammatory bowel disease Study Group (GEDII) physician database, we invited PGE to participate in an anonymous online survey. Results: Fifty-six physicians agreed to participate in the study. Deep remission, steroid-free clinical remission, endoscopic remission, and biomarker remission were ranked among the most important treatment targets in CD (89%, 80%, 89%, and 84%, respectively) and UC (82%, 84%, 79%, and 84%, respectively). In CD, transmural remission was considered a target by 70% of participants, with 48% agreeing to intensify treatment to achieve it. In UC, histological remission was aimed by only 45% of PGE with most (88%) being unwilling to intensify treatment to achieve this goal. Physicians were more likely to seek endoscopic remission in CD and UC in younger and healthier patients, compared to older patients with comorbidities. Conclusion: PGEs are increasingly pursuing tougher treatment targets such as transmural remission in CD and, to a lesser extent, histological remission in UC. Physicians are more willing to escalate treatment to achieve endoscopic remissioninyounger patients.
dirty 0
eu_rights_str_mv openAccess
format article
id scielopt_96c235e4e8f2deed5b6816ff137bb98b
identifier.url.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452025000400047
instacron_str SciELO
institution Fundação para a Ciência e Tecnologia
instname_str Fundação para a Ciência e Tecnologia
language eng
network_acronym_str scielopt
network_name_str SciELO Portugal
oai_identifier_str oai:scielo:S2341-45452025000400047
organization_str_mv urn:organizationAcronym:scielo
person_str_mv Sousa,Diogo Couto
Fernandes,Samuel Raimundo
Bernardo,Sónia
Correia,Luís
Cortez-Pinto,Helena
Magro,Fernando
publishDate 2025
publisher.none.fl_str_mv Sociedade Portuguesa de Gastrenterologia
reponame_str SciELO Portugal
repository_id_str urn:repositoryAcronym:scielopt
service_str_mv urn:repositoryAcronym:scielopt
spelling Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese GastroenterologistsSousa,Diogo CoutoFernandes,Samuel RaimundoBernardo,SóniaCorreia,LuísCortez-Pinto,HelenaMagro,FernandoInflammatory bowel diseaseTransmural remissionHistological remissionopen accesshttp://purl.org/coar/access_right/c_abf2http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452025000400047URLhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452025000400047URLHasVersion2025-08-01Abstract Background: In 2018, the authors surveyed the clinical practices among Portuguese gastroenterologists (PGEs) regarding treatment targets in Crohn’s disease (CD) and ulcerative colitis (UC). Since then, new evidence has emerged supporting additional targets, such as transmural remission and histological remission. This study provides an updated assessment of treatment practices among PGE with special emphasis on these new targets. Methods: Using the Portuguese Inflammatory bowel disease Study Group (GEDII) physician database, we invited PGE to participate in an anonymous online survey. Results: Fifty-six physicians agreed to participate in the study. Deep remission, steroid-free clinical remission, endoscopic remission, and biomarker remission were ranked among the most important treatment targets in CD (89%, 80%, 89%, and 84%, respectively) and UC (82%, 84%, 79%, and 84%, respectively). In CD, transmural remission was considered a target by 70% of participants, with 48% agreeing to intensify treatment to achieve it. In UC, histological remission was aimed by only 45% of PGE with most (88%) being unwilling to intensify treatment to achieve this goal. Physicians were more likely to seek endoscopic remission in CD and UC in younger and healthier patients, compared to older patients with comorbidities. Conclusion: PGEs are increasingly pursuing tougher treatment targets such as transmural remission in CD and, to a lesser extent, histological remission in UC. Physicians are more willing to escalate treatment to achieve endoscopic remissioninyounger patients.Sociedade Portuguesa de GastrenterologiaGE-Portuguese Journal of Gastroenterology v.32 n.4 2025text/htmlengjournal articlehttp://purl.org/coar/resource_type/c_6501literature
spellingShingle Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese Gastroenterologists
Sousa,Diogo Couto
Inflammatory bowel disease
Transmural remission
Histological remission
status SINGLETON
subject.fl_str_mv Inflammatory bowel disease
Transmural remission
Histological remission
title Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese Gastroenterologists
title_full Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese Gastroenterologists
title_fullStr Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese Gastroenterologists
title_full_unstemmed Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese Gastroenterologists
title_short Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese Gastroenterologists
title_sort Treat-to-Target in Inflammatory Bowel Disease: An Updated Survey of Treatment Strategies among Portuguese Gastroenterologists
topic Inflammatory bowel disease
Transmural remission
Histological remission
topic_facet Inflammatory bowel disease
Transmural remission
Histological remission
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452025000400047
visible 1